When you’re worried about your health, you need to find answers – fast. Changes in your prostate do not mean you have cancer, but an appointment at our One Stop Urology clinic can identify if there is a problem.

 

You can book a private appointment with one of our consultant urology surgeons. All of the necessary tests will be carried out on the same day all under one roof. Our consultants are supported by a whole team of healthcare professionals, including radiologists and nurse specialists.

Being Prostate Aware

 

As men age, the prostate grows larger, and this can cause symptoms, which can have an impact on your quality of life. Such enlargement is commonly benign (non-cancerous) but if you notice any changes then call us to book an appointment.

The first signs of prostate problems can include:

  • A weak or slow urinary stream
  • A feeling of incomplete bladder emptying
  • Difficulty starting urination
  • Frequent urination
  • Urgency to urinate
  • Getting up frequently at night to urinate
  • A urinary stream that starts and stops
  • Straining to urinate

Appointments that fit around you

We offer flexible consultations, in a relaxed, calm and comfortable environment.

Our multidisciplinary team provide a comprehensive service and cover all aspects of urological conditions.

Led by our expert urology consultants, the one stop clinic offers rapid access to ensure you get a comprehensive assessment for a quick and accurate diagnosis.

Our screening process includes:

  • A consultation with a leading Urologist
  • Discussion of your PSA blood test results if already done by your GP
  • Assessment of your symptoms and review of your voiding diary (this is a daily record of your fluid intake and urinary output)
  • A pre – clinic questionnaire to assess your urinary symptoms
  • A urine analysis: you will be asked to bring a fresh urine specimen (a container can be provided)
  • A rectal examination of the prostate gland and an examination of the abdomen
  • A flow rate and residual urinary volume assessment to determine if your urine flow rate is restricted and whether there is effective emptying of the bladder. For this test you will need to come to the appointment with a comfortably full bladder.

 

Results

We will discuss the results of the assessments with you and provide relevant lifestyle and dietary advice. This is all also provided in a written report that is sent to you and your GP. We will also advise you If further tests are needed.

Imaging and diagnostic procedures

If a CT scan is required, this can be provided at the centre, with results available in 48 hours.

If we need to get a better view of your prostate or your consultant suspects there may be an abnormality in your prostate gland, we may need to do a multi parametric MRI (mpMRI). We can arrange an MRI for you at our Windsor or Oxford centres.

Call us now to book your appointment

It’s okay to call us yourself, but we will require a GP referral which you can bring on the day. We’re recognised by all the major private medical insurance providers but it’s always best to check that you are covered with your insurer prior to the appointment. So, if you have any concerns, or just want a second opinion, contact us today to book your appointment.

What’s next?

At our One Stop Urology Clinic you’ll get a fast diagnosis and, if you need treatment, we’ll work with you to develop a personalised treatment plan.

Paying for your treatment

Your private medical insurance may cover the costs of this clinic so it’s always best to check with them first to understand the extent of cover provided. If you would like to self- pay, we can arrange a competitive quote to help you make your decision.

Our specialists

Mr Christof Kastner

Consultant Urologist

Dr Saeb Parsy

Consultant Urologist

Contact us

You can find us at:

The Oaks, Fordham Road, Newmarket, CB8 7XN

Email: newmarket.enquiries@genesiscare.com
Phone: 01223 816 797
Fax: +44 (0)1638 662 134

Learn more

We'd love to hear from you

Make an enquiry

Search for a centre near you

Birmingham

Little Aston Hall Drive, Sutton Coldfield, B74 3BF

+44 (0)121 353 3055

Bristol

300 Park Avenue, Aztec West, Bristol, BS32 4SY

01454 456500

Chelmsford

Springfield Cancer Centre, Lawn Lane, Chelmsford, CM1 7GU

+44 (0)1245 987 901

Cromwell Hospital

164-178 Cromwell Rd, Kensington, London SW5 0TU, UK

020 7460 5626

Elstree

Unit 710, Centennial Park, Centennial Avenue, Elstree, Borehamwood, WD6 3SZ

+44 (0)208 236 9040

Guildford

BMI St Martha Oncology Centre, 46 Harvey Road, Guildford, GU1 3LX

+44 (0)1483 806 000

Maidstone

17 Kings Hill Avenue, Kings Hill, West Malling, ME19 4UA

+44 (0)1732 207 000

Milton Keynes

Sunrise Parkway, Linford Wood East, Milton Keynes, MK14 6LS

+44 (0)1908 467 700

Newmarket

The Oaks, Fordham Road, Newmarket, CB8 7XN

+44 (0)1223 907 600

Nottingham

The Park Centre for oncology, Sherwood Lodge Drive, Burntstump Country Park, Nottingham, NG5 8RX

+44 (0)115 966 2250

Oxford

Sandy Lane West, Peters Way, Oxford, OX4 6LB

+44 (0)1865 237 700

Portsmouth

Bartons Road, Havant, PO9 5NA

+44 (0)23 9248 4992

Southampton

Spire Hospital, Chalybeate Close, Southampton, SO16 6UY

+44 (0)238 076 4961

Windsor

69 Alma Road, Windsor, SL4 3HD

+44 (0)1753 418 444

 

177Lutetium PSMA therapy, or Prostate-Specific Membrane Antigen therapy, is an innovative molecular therapy used to treat advanced prostate cancer. It precisely targets cancerous cells, avoiding damage to surrounding healthy tissue.

How does 177Lutetium PSMA therapy work?

177Lutetium PSMA therapy uses a molecule which attaches itself to the PSMA receptors on the cancer cells. Before it’s given, the PSMA molecule is bound with 177Lutetium, a radioactive substance that damages and destroys prostate cancer cells in a targeted way. The PSMA molecule carries the 177Lutetium straight to the tumour site so the whole body isn’t exposed to radiation.

 

What are the benefits of 177Lutetium PSMA therapy?

This therapy helps:

  • Reduce the size of the tumour and stop it growing
  • Improve the symptoms caused by the tumour
  • Maintain and improve quality of life

After treatment, some patients have a long period of remission and significant improvements in their quality of life.

When would I consider this treatment for my patient?

This therapy is most often used when prostate cancer has metastasised and when other therapies are poorly tolerated or have failed. In certain patients, it appears to be able to produce long term remission.

Before the patient starts treatment they will have a diagnostic GA-68 PSMA PET/CT scan to help identify the location of the cancer. This also helps in staging and planning of treatment.

If the PET/CT scan shows that the patient could benefit from 177Lutetium therapy they will be offered an appointment to discuss what’s involved. We may also ask them to complete a short questionnaire about their general health to help assess whether this treatment is right for them.

Therapy is delivered as an outpatient procedure at our Theranostics suite in Windsor. On the day of treatment the radioactive 177Lutetium will be injected, followed by 1-2 litres of saline. Each cycle is delivered over four hours via a drip inserted into a vein in the arm. The treatment cycle is usually cyclical and normally involves four treatments carried out 6 – 8 weeks apart. Most people have four to six cycles of treatment.

Therapy is personalised according to response and symptoms. Blood tests are carried out before each cycle to check how well things are going.

We will arrange follow up appointments before the patient leaves the department.

Like all cancer treatments, there can be side-effects. These vary from person to person, but may include:

  • Dry mouth
  • Tiredness
  • Mild nausea
  • Loss of appetite

Some patients may produce fewer blood cells than normal for a while. But they’ll be offered regular blood tests to check everything’s OK. We’ll help find ways to reduce and manage any side-effects including medication to reduce any symptoms.

Before the patient starts treatment they will have a diagnostic GA-68 PSMA PET/CT scan to help identify the location of the cancer. This also helps in staging and planning of treatment.

If the PET/CT scan shows that the patient could benefit from 177Lutetium therapy they will be offered an appointment to discuss what’s involved. We may also ask them to complete a short questionnaire about their general health to help assess whether this treatment is right for them.

Therapy is delivered as an outpatient procedure at our Theranostics suite in Windsor. On the day of treatment the radioactive 177Lutetium will be injected, followed by 1-2 litres of saline. Each cycle is delivered over four hours via a drip inserted into a vein in the arm. The treatment cycle is usually cyclical and normally involves four treatments carried out 6 – 8 weeks apart. Most people have four to six cycles of treatment.

Therapy is personalised according to response and symptoms. Blood tests are carried out before each cycle to check how well things are going.

We will arrange follow up appointments before the patient leaves the department.

Like all cancer treatments, there can be side-effects. These vary from person to person, but may include:

  • Dry mouth
  • Tiredness
  • Mild nausea
  • Loss of appetite

Some patients may produce fewer blood cells than normal for a while. But they’ll be offered regular blood tests to check everything’s OK. We’ll help find ways to reduce and manage any side-effects including medication to reduce any symptoms.

Easy Access

Cancer care at GenesisCare may be covered by private medical insurance – we’re recognised by most major insurers. We also offer a range of self-pay packages.

Theranostics is offered at our Windsor centre.

How to refer a patient

Please send a referral/clinic letter to windsor.enquiries@genesiscare.com

For more information

Contact us directly
Tel: 01753 418 444
Email: theranosticsUK@genesiscare.co.uk

Meet Dr Yong Du

 

Who may benefit?

Theranostics can be used to treat cancers that have spread (metastasised), or where cancer is advanced and/or hasn’t responded to other treatments.

While in the future theranostics may be used for different cancers, to date most experience and success has been in metastatic prostate cancer and neuroendocrine tumours.

Metastatic prostate cancer

c

 

How it works

Theranostics is a personalised approach to treating cancer, using both diagnosis and therapy tools as part of the treatment.

Theranostics uses PET scan imaging (a special type of scan) to see if specific targets, known as tumour receptors, are present on tumour cells. If these targets are present and visible on the scan, a radioactive drug is used to treat the tumours. The drug is given as an injection and selectively targets the tumour cells while avoiding healthy areas. Most of the radioactive drug that doesn’t reach the target is quickly passed out of the body.

 

 

Theranostics is not suitable for all patients, but may be an option in metastatic disease unresponsive to or unsuitable for conventional therapies. Most evidence to date is in metastatic castrate resistant prostate cancer and advanced neuroendocrine tumours (NETs).

  • A Phase 2 study (n=30) of 177Lu-PSMA-617 showed ‘high response rates, low toxicity effects, and a reduction in pain in men with metastatic castration-resistant prostate cancer who have progressed after conventional treatments’1.
  • In Phase 3 study, NETTER–1*, ’177Lu-Dotatate resulted in markedly longer progression-free survival than high-dose octreotide LAR and was associated with limited acute toxic effects in a population of patients who had progressive neuroendocrine tumours that originated in the midgut’2.

 

Available services

  • 177Lutetium PSMA – for Metastatic or Treatment Resistant Prostate Cancer
  • 177Lutetium Octreotate – for somatostatin receptor – positive tumours (available from Autumn 2019)

Easy access

Cancer treatment at GenesisCare may be covered by insurance. We also offer self-pay options for Theranostics.

How to refer a patient

Please send a referral/clinic letter to windsor.enquiries@genesiscare.com

For more information

Contact us directly
Tel: 01753 418 444
Email: theranosticsUK@genesiscare.co.uk

1. Hofman, et al. Lancet Oncol; 2018; 19: 825–33
2. Strosberg, et al. N Engl J Med; 2017; 376: 125-135

 

What is PBMT?

 
PBMT uses a low-intensity laser beam aimed at various parts of your mouth, helping to reduce Oral mucositis (OM) which is when the lining of your mouth becomes inflamed – a common side effect of radiotherapy and chemo-radiotherapy treatment for head & neck cancer.

OM can be painful. You may have difficulty swallowing. You may also lose weight. In some cases, you might need to have additional medication, or even a feeding tube, as well as more frequent appointments with your multidisciplinary head & neck team.

How can PBMT help?

 
PBMT is an effective treatment that can reduce the severity and duration of OM. It’s been used for more than 20 years to help reduce this side-effect in patients with head & neck cancers.

It can help by:

  • Encouraging the tissues inside the mouth to heal
  • Reducing inflammation and risk of ulcers
  • Enabling you to swallow more comfortably
 
 

  • Reducing pain (so you don’t need to take as much pain relief medicine)
  • Making it less likely that you’ll need to be fed via a tube
  • Improving your quality of life

How does PBMT work with my radiotherapy treatment?

 
You’ll receive your first PBMT treatment a couple of hours before your first radiotherapy session. Then around 30 minutes before all other radiotherapy sessions. It’s delivered by specially trained PBMT radiographers and takes approximately 30 minutes. You will be asked to wear goggles to ensure your eyes are protected during each treatment.

We advise that you should avoid alcohol and not smoke throughout the course of your treatment. We also provide access to a dietician to assist you.

Are there any side-effects from PBMT?

 
PBMT is painless, and there are no known side-effects.

Where can you have PBMT?

You can be treated with PBMT at our Southhampton centre:

Spire Hospital, Chalybeate Close, Southampton, SO16 6UY

Telephone: 0238 189 0624
Email: southampton.enquiries@genesiscare.com

We have free on-site parking.

Learn more

Meet our doctors

Everything we do is focused on designing better care for our patients. With a network of 12 specialist oncology treatment centres across the UK, we provide the most up-to-date treatments and technology as standard.

We attract and retain some of the most experienced doctors in the country, who all have a passion for improving patient outcomes and specialise in the treatment of different types of cancer.

Meet our doctors

 

Before your treatment begins, you’ll be offered a PET/CT scan. The scan helps us identify cancerous targets called tumour receptors so we can precisely plan your treatment.

What is a PET/CT Scan?

A PET/CT scan combines two imaging techniques: Positron Emission Tomography (PET) and Computerised Tomography (CT). PET produces 3-D images of your body and allows us to look at your metabolism and other important functions. We can also study any changes that are happening over time while we monitor your condition. The CT scan uses computer-processed X-ray measurements to create a detailed image.

How does it work?

Before carrying out a PET/CT scan, a ‘tracer’ (a type of radioactive substance) will be injected in to your arm, hand, or foot. The tracer spreads through the body and gives off a type of radiation that shows up on the PET scan. This allows the scanner to build up a detailed image that identifies areas of the body affected by disease, as well as some of the body’s functions.

The PET scans are combined with CT scans which adds the precision of anatomic localisation to functional imaging enabling a more accurate diagnosis. The CT scanner takes a series of cross-sectional images (‘slices’) and then computer processing is used to construct a three-dimensional image.

Using this method, we can get important information about many conditions affecting different parts of the body. The combination of scans shows the precise shape, location and size of your tumour. It helps your specialist to make an accurate diagnosis and plan the best treatment for you. The scan is safe and doesn’t hurt.

Having a PET/CT scan

A radiographer will ask you to lie on the scanner bed and make you as comfortable as possible. The scanner bed will move gently and slide you into the centre of the scanner until the part of the body to be scanned is correctly positioned. While the scan is taking place, you’ll need to remain still.

The scan takes between 20 and 45 minutes but there’s also some preparation time, so you’ll need to allow about two hours for the appointment.

Side-effects

The amount of radioactivity injected in the tracer is relatively small and will be excreted by your kidneys (passed when you urinate). It will not produce any side effects. You can eat, drink and travel as normal after the test. However, as a precaution, we advise our patients to avoid having close contact with young children and pregnant women for 4 – 6 hours after leaving the department.

The test is not advised if you are pregnant or are breast feeding.

Philip's experience of a PET/CT scan

Find out more

For more information about a private PET/CT scan at GenesiscCare please call:

Oxford:01865 706 098

Windsor: 01753 343 213

Or complete the enquiry form below and we’ll come back to you – usually within 24 hours

Make an enquiry

Meet our doctors

Everything we do is focused on designing better care for our patients. With a network of 12 specialist oncology treatment centres across the UK, we provide the most up-to-date treatments and technology as standard.

We attract and retain some of the most experienced doctors in the country, who all have a passion for improving patient outcomes and specialise in the treatment of different types of cancer.

Meet our doctors

 

You may be offered 177Lutetium octreotate therapy if you have neuroendocrine tumours (NETs) including head and neck cancers and gastrointestinal tumours. It’s one of a group of innovative treatments known as Peptide Receptor Radionuclide Therapy (PRRT). It precisely targets cancerous cells, reducing damage to healthy tissue.How does 177Lutetium octreotate therapy work?
Cells in the body have different kinds of receptors on their surface. The receptors enable cells to send the signals that coordinate body functions. This allows them to respond to changes in their environment.
The endocrine system produces a hormone called somatostatin. Somatostatin has many functions in the body so many cells have receptors for it. NETs have many somatostatin receptors on their surface.Octreotate is a synthetic (man-made) hormone and is similar to the body’s natural somatostatin. Used in combination with a targeted radioactive substance called lutetium-177, octreotate travels to the somatostatin receptors, including NET cells, and locks on to them. This enables the cancerous cells to be precisely targeted with radiotherapy. It avoids the whole body being exposed to radiation. It’s cleared from your body when you urinate.

Why would I be offered 177Lutetium octreotate therapy?

You may be offered 177Lutetium octreotate therapy if you have tumours that start in your endocrine or nervous system. These are known as neuroendocrine tumours (NETs). It is used when other types of treatment, such as surgery or chemotherapy, aren’t suitable or haven’t worked.

This therapy helps to:

  • Stop the NETs from growing
  • Reduce the size of the tumour
  • Improve your symptoms

In some cases, NETs reduce in size for a long period of time, giving long-term remission from the disease, but this therapy can’t cure your cancer.

Further information

Before you start treatment, you’ll have a diagnostic PET/CT scan.

The scan helps us to see whether the cancer has somatostatin receptors. It identifies the location of the cancer so that it can be precisely targeted and helps in staging and planning your treatment.

177Lutetium octreotate therapy is an outpatient procedure in our Theranostics suite. Your treatment will be delivered over four hours by a drip inserted into a vein in your arm.

Most people have four treatment carried out at 4-8 week intervals between treatments. Your therapy will be personalised according to your response and symptoms.

177Lutetium is cleared from your body when you urinate, with 60% eliminated within 24 hours of treatment.

Like all cancer treatments, there can be side-effects. They vary from person to person, but may include:

  • Fatigue
  • Nausea
  • A temporary increase in your cancer symptoms

We’ll help you find ways to reduce and manage any side-effects. You may be able to have medication to reduce any symptoms.

Before you start treatment, you’ll have a diagnostic PET/CT scan.

The scan helps us to see whether the cancer has somatostatin receptors. It identifies the location of the cancer so that it can be precisely targeted and helps in staging and planning your treatment.

177Lutetium octreotate therapy is an outpatient procedure in our Theranostics suite. Your treatment will be delivered over four hours by a drip inserted into a vein in your arm.

Most people have four treatment carried out at 4-8 week intervals between treatments. Your therapy will be personalised according to your response and symptoms.

177Lutetium is cleared from your body when you urinate, with 60% eliminated within 24 hours of treatment.

Like all cancer treatments, there can be side-effects. They vary from person to person, but may include:

  • Fatigue
  • Nausea
  • A temporary increase in your cancer symptoms

We’ll help you find ways to reduce and manage any side-effects. You may be able to have medication to reduce any symptoms.

Easy Access

 

Cancer care at GenesisCare may be covered by private medical insurance – we’re recognised by most major insurers. We also offer a range of self-pay packages.
We offer Theranostics at our Windsor Centre, you can choose from a range of appointment times and we can schedule your treatment to suit your needs.

How to find us

Make an enquiry about 177Lutetium octreotate therapy

Whether you’re in need of treatment or would like more information please complete our enquiry form and we will get back to you – usually within 24 hours.

Make an enquiry

DR-Yong

Meet Dr Yong Du

Dr Yong Du
MBBS MSc PhD FRCP

Dr Yong Du is a Consultant Physician in Nuclear Medicine & PET/CT. He has extensive experience in both Diagnostic and Therapeutic Nuclear Medicine and was the first recipient of the UK HEFCE Clinical Senior Lectureship award in the Nuclear Medicine specialty.

Learn more

 

177Lutetium PSMA therapy, or Prostate-Specific Membrane Antigen therapy, is an innovative molecular therapy used to treat advanced prostate cancer. It’s one of a group of treatments known as Peptide Receptor Radionuclide Therapy (PRRT). It precisely targets cancerous cells, avoiding damage to surrounding healthy tissue.

How does 177Lutetium PSMA therapy work?

PSMA is a type of protein located on the surface of a cell. It’s found on the prostate gland.

If you have prostate cancer, you’ll have more PSMA than normal. If the prostate cancer has spread to other parts of the body (metastasised), the PSMA will also be there.

177Lutetium PSMA therapy uses a molecule which attaches itself to the PSMA receptors on the cancer cells. Before it’s given to you, the PSMA molecule is bound with 177Lutetium. This is a radioactive substance. It damages and destroys prostate cancer cells in a targeted way, with minimal damage to healthy cells. The PSMA molecule carries the 177Lutetium straight to the tumour site so your whole body isn’t exposed to radiation.

Why would I be offered this treatment?

You may be offered 177Lutetium PSMA therapy if your prostate cancer has spread and other therapies have failed.

This therapy helps:

  • Reduce the size of the tumour and stop it growing
  • Improve your symptoms
  • Maintain and improve quality of life

After treatment, some patients have a long period of remission and significant improvements in their quality of life, but it doesn’t cure your cancer.

Further information

Before you start treatment, you’ll have a diagnostic PET/CT scan. The scan identifies the location of the cancer and helps in staging and planning your treatment.

177Lutetium PSMA therapy is an outpatient procedure in our Theranostics suite. Your treatment will be delivered over four hours by a drip inserted into a vein in your arm.

Most people have four treatments carried out 6-8 week apart. Your therapy will be personalised according to your response and symptoms.

177Lutetium is cleared from your body when you urinate, with 60% eliminated within 24 hours of treatment.

Like all cancer treatments, there can be side-effects. These vary from person to person, but may include:

  • Dry mouth
  • Tiredness
  • Mild nausea
  • Loss of appetite

You may also produce fewer blood cells than normal for a while. But you’ll be offered regular blood tests to check everything is OK.

We’ll also help you find ways to reduce and manage any side-effects and you may be able to have medication to reduce any symptoms.

Before you start treatment, you’ll have a diagnostic PET/CT scan. The scan identifies the location of the cancer and helps in staging and planning your treatment.

177Lutetium PSMA therapy is an outpatient procedure in our Theranostics suite. Your treatment will be delivered over four hours by a drip inserted into a vein in your arm.

Most people have four treatments carried out 6-8 week apart. Your therapy will be personalised according to your response and symptoms.

177Lutetium is cleared from your body when you urinate, with 60% eliminated within 24 hours of treatment.

Like all cancer treatments, there can be side-effects. These vary from person to person, but may include:

  • Dry mouth
  • Tiredness
  • Mild nausea
  • Loss of appetite

You may also produce fewer blood cells than normal for a while. But you’ll be offered regular blood tests to check everything is OK.

We’ll also help you find ways to reduce and manage any side-effects and you may be able to have medication to reduce any symptoms.

Easy Access

 

Cancer care at GenesisCare may be covered by private medical insurance – we’re recognised by most major insurers. We also offer a range of self-pay packages.
We offer Theranostics at our Windsor Centre, you can choose from a range of appointment times and we can schedule your treatment to suit your needs.

How to find us

Make an enquiry about 177Lutetium PSMA therapy

Whether you’re in need of treatment or would like more information please complete our enquiry form and we will get back to you – usually within 24 hours.

Make an enquiry

DR-Yong

Meet Dr Yong Du

Dr Yong Du
MBBS MSc PhD FRCP

Dr Yong Du is a Consultant Physician in Nuclear Medicine & PET/CT. He has extensive experience in both Diagnostic and Therapeutic Nuclear Medicine and was the first recipient of the UK HEFCE Clinical Senior Lectureship award in the Nuclear Medicine specialty.

Learn more

 

We design our care to help give patients the best possible life outcomes. Which is why we offer SpaceOAR® Hydrogel as part of our standard pre‑radiotherapy treatment, at no extra cost.

What is SpaceOAR® Hydrogel?

SpaceOAR® Hydrogel is an absorbable, water based soft gel implant. It has been designed to reduce radiation exposure to healthy organs and tissue surrounding the prostate.

It helps reduce the potential short and long-term side effects from radiotherapy, such as; rectal bleeding, bowel leakage, urinary incontinence, erectile dysfunction.

How does it work?

SpaceOAR® Hydrogel creates space between the prostate gland and rectum, enabling a more accurately targeted radiation dose to the prostate while avoiding unnecessary radiation to the normal tissue.
c

Clinically tested, reviewed and approved

In a prospective multi-centre, randomised clinical trial across 20 sites in the US involving 222 patients with prostate cancer (randomised 2:1, spacer vs control) spacer placement accuracy was reported in 99% of patients in the spacer group2.

Studies of SpaceOAR® Hydrogel have appeared in more than 60 peer-reviewed papers and more than 35,000 men have already undergone the procedure worldwide.

SpaceOAR® Hydrogel has received positive NICE guidance.

What are the benefits?

In a randomised clinical trial, at a median three-year follow-up, SpaceOAR® Hydrogel patients experienced reduced side-effects from prostate cancer radiation, including:

  • 78% more likely to retain sexual function 3***
  • 74% relative reduction in rectal V70 1*
  • 66% fewer clinically significant declines in urinary QOL 2**
  • 0% Late Grade 2 or higher rectal toxicity 2

How is SpaceOAR® Hydrogel implanted?

Implanting SpaceOAR® Hydrogel is a minimally invasive procedure that takes around 30 minutes.

Our urologists use a needle to insert the gel between the prostate and the rectum using an ultrasound guided transperineal approach. The water-soluble gel stays in position during the radiotherapy treatment cycle (four to seven weeks) then naturally biodegrades to be absorbed by the body over three months.

The procedure is performed at one of our national partner hospitals as a day case by urologists in the GenesisCare network. We have a national network of partner hospitals and also work in partnership with Nuffield Health, the largest not-for-profit UK healthcare organisation, to offer your patients the nearest local hospital for their procedure.

They’ll receive their radiotherapy at their local GenesisCare centre.

How to refer a patient

Please complete the form below to request a call back and we will be in contact shortly to assist with any questions you may have in relation to completing a referral form.

Request a call back

Please provide the following details and we’ll call you back to complete your referral.